StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Pre-Tax Income (Switzerland Domicile) by Year

Pre-Tax Income (Switzerland Domicile) ($M)

Novartis Pre-Tax Income (Switzerland Domicile): $16,681M in FY2025, up 65.2% from a year earlier.

Latest, FY2025
16,681
Period ended Dec 31, 2025
Change on a year earlier
+65.2%
10,098 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Reported in Form 20-F Note 6.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPre-Tax Income (Switzerland Domicile) ($M)Year on yearSource
FY2025Dec 31, 202516,681+65.2%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 202410,098+3.9%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 20239,719+69.0%Novartis Form 20-F (0001114448-26-000004) ↗
FY2022Dec 31, 20225,751-73.7%Novartis Form 20-F (0001370368-25-000004) ↗
FY2021Dec 31, 202121,830+123.1%Novartis Form 20-F (0001370368-24-000004) ↗
FY2020Dec 31, 20209,786+20.9%Novartis Form 20-F/A (0001370368-23-000048) ↗
FY2019Dec 31, 20198,097-31.9%Novartis Form 20-F (0001370368-22-000010) ↗
FY2018Dec 31, 201811,887+120.7%Novartis Form 20-F (0001370368-21-000006) ↗
FY2017Dec 31, 20175,385+73.2%Novartis Form 20-F (0001370368-20-000003) ↗
FY2016Dec 31, 20163,110–Novartis Form 20-F (0001370368-19-000002) ↗

Cite this data

StockData. (2026). Novartis Pre-Tax Income (Switzerland Domicile) ($M), annual FY2016–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/tax-pretax-ch

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.